METiS Therapeutics
About:
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Website: https://www.metistx.com/
Twitter/X: MetisTx
Top Investors: HongShan, Frees Fund, Lightspeed China Partners, CMB International Capital Corporation, Monolith Management
Description:
METiS Therapeutics is a biotechnology company that aims to drive therapies in a wide range of disease areas by integrating drug discovery and delivery with AI, machine learning, and quantum simulation.
Total Funding Amount:
$176M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Cambridge, Massachusetts, United States
Founded Date:
2017-01-01
Contact Email:
contact(AT)metistx.com
Founders:
Chris Lai
Number of Employees:
11-50
Last Funding Date:
2022-04-05
IPO Status:
Private
Industries:
© 2025 bioDAO.ai